INVIVO THERAPEUTICS HOLDINGS CORP. 4
4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Jan 20, 2017
Insider Transaction Report
Form 4
Ulich Thomas R
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-01-18+150,000→ 150,000 totalExercise: $4.35Exp: 2027-01-18→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.